The complaint alleges that Celsius failed to disclose potential health hazards tied to its Alani Nu products, particularly concerning the marketing of these drinks to consumers under 18. According to the filing, these omissions rendered the company's public statements materially misleading throughout the specified class period. When the market eventually reconciled with these undisclosed risks, investors incurred significant financial losses.
Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs for the action, which cites violations of the Securities Exchange Act of 1934. Shareholders have until November 3, 2026, to take action. Those wishing to discuss their rights or the potential for recovery may contact Brian Schall or David Schwartz at the firm’s Los Angeles office. As the class has not yet been certified, affected investors are not currently represented by counsel and retain the choice to remain absent members or participate in the litigation.




Comments (0)
No comments yet. Be the first!